Biosimilars/Biobetters Pipeline Directory Description/Flyer

• The most comprehensive and cost-effective follow-on biopharmaceuticals (biosimilars, biobetters and biogenerics) pipeline information resource!
• Essential and inexpensive too!  The Directory defines the industry common denominator of knowledge and competitive intelligence concerning the products it covers (what your competitors with access know, but you don't).  Less than $.40/pipeline product record [compare that to any other pipeline resource].
• Authored by the author/publisher of BIOPHARMA  Biopharmaceutical Products in the U.S. and European Markets (www.biopharma.com), "The Reference Products Reference," since 2001 the only information resource/reference specializing in biopharmaceutical products. 

• Contents (3/14/2017)
      1,496 product records total
         828 biosimilar product records
          511 biobetter product records
         146 reference product records
     >7,000 product index terms, mostly indications
      678 company records; 170 cross-reference entries

• Coverage - all follow-on biopharmaceuticals in development or marketed worldwide
• biosimilars - genuine biosimilars; follow-ons targeted to highly-regulated countries with approvals based on extensive comparative analytical and clinical (bio)similarity testing, with GMP manufacturing
• biogenerics - "biosimilars" not generally on track for or with approvals in highly-regulated countries, generally without GMP manufacturing and rigorous biosimilar analytical or clinical testing and approvals, generally, marketed in lesser- and non-regulated countries and international commerce [Note, an indexing field distigunishes between biosimilars/highly-regulated major markets targeted vs. biogenerics/lesser-regulated international markets targeted].
• biobetters - Products too innovative or otherwise too different relative to any reference product to receive approval as a biosimilar

Only recombinant and other cultured/fermented protein-based products are included.  Classic biologics are excluded - vaccines, blood/plasma and cellular products.  Over 95% of products are recombinant proteins.

Product information - Product records include:
      agent/product generic name(s)
      agent/product trade name(s)
      reference product
      stage/phase of development
      companies involved
      country/region for companies involved
      indexing (mostly indications)
      major market/GMP vs. lesser-regulated/non-GMP (biogeneric) products tagged
      notes regarding the products and company involvement
      Cross-references (links in the databases) between product and company records

Company information - Company records include:
      company name(s), including cross-references
      country
      region/continent
      products company is involved with
      company annual revenue range
      notes and links to related products
      Cross-references (links in the databases) between company and product records

Currency - Updated at least quarterly. Last full update on Jan. 18, 2017.

Formats and Prices - 2 options

1. Database annual subscription options
   • $600/year - "individual" or password-based subscription (database at this site). "Individual" passwords may be reasonably shared much as a book version might be shared, such as with colleagues working on the same projects, in same department, etc.
   • $1,000 - company worldwide access; automatic access for all by server IP numbers (no logging in required); inquire about discounts
   • Bundled online subscriptions to the Directory PLUS BIOPHARMA:  Biopharmaceutical Products in the U.S. and European Markets ("The Reference Products Reference") - inquire about prices/discounts; BIOPHARMA includes U.S. and EU biosimilar and biobetter launchability dates (patent, market and data exclusivity expiration dates) for >140 reference products, plus much unique bioprocessing, patent/licensing, regulatory and other information essential to follow-on products development, much of it available nowhere else.  
2. PDF file/Print format
   $400 - 1-time/current PDF file version with same content as databases; product and company main sections and indexes with cross-references between products and companies; ready for use as PDF or you may print it for personal use

Payment options - Check ($US) or credit charge.  payments made to and orders filled by BioPlan Associates, Inc.

Satisfaction guaranteed - Full refund within a month, if you don't learn information that affects your company, your perspectives, etc. 

For sales inquiries and purchases; 9AM-5PM Eastern U.S. time:
BioPlan Associates, Inc.
2275 Research Blvd., Suite 500
Rockville, MD 20858
Phone: (301) 921-5979
Email: info@bioplanassociates.com

For database/PDF content-related inquiries and database user support; 9AM-5PM Eastern U.S. time:
Ronald A. Rader (author)
President
Biotechnology Information Institute
1700 Rockville Pike, Suite 400
Rockville, MD 20852
Phone: 301-424-0255
E-mail: biosimilars@comcast.net

Copyright©2017, Biotechnology Information Institute